{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:18:16Z","timestamp":1788049096556,"version":"build-2784847793"},"reference-count":178,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119213","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:15:25Z","timestamp":1785885325000},"page":"119213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In vivo imaging of lipid nanoparticle messenger RNA therapeutics: Current advances and emerging opportunities"],"prefix":"10.1016","volume":"318","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-8695","authenticated-orcid":false,"given":"Natacha","family":"Jugniot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119213_bib1","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119213_bib2","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2026.119213_bib3","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.omtn.2023.05.004","article-title":"The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system","volume":"32","author":"Bernard","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2026.119213_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102456","article-title":"CleanCap M6 inhibits decapping of exogenously delivered IVT mRNA","volume":"36","author":"Mandell","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2026.119213_bib5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/mt.2015.103","article-title":"Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals","volume":"23","author":"Thess","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2026.119213_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Karik\u00f3","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119213_bib7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics \u2014 developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119213_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41573-023-00827-x","article-title":"Tailor made: the art of therapeutic mRNA design","volume":"23","author":"Metkar","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119213_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41573-024-00977-6","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery","volume":"23","author":"Cullis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119213_bib10","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejmech.2026.119213_bib11","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119213_bib12","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119213_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/00185787241298140","article-title":"Respiratory syncytial virus vaccine (mRNA)","volume":"60","author":"Levien","year":"2025","journal-title":"Hosp. Pharm."},{"key":"10.1016\/j.ejmech.2026.119213_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.119213_bib15","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2026.119213_bib16","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1038\/s41467-024-47905-1","article-title":"Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials","volume":"15","author":"H\u1ed3","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119213_bib17","article-title":"MRI\/PET multimodal imaging of the innate immune response in skeletal muscle and draining lymph node post vaccination in rats","volume":"13","author":"Madi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.119213_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1039\/D4PM00128A","article-title":"Tailoring lipid nanoparticle dimensions through manufacturing processes","volume":"1","author":"McMillan","year":"2024","journal-title":"RSC Pharm"},{"key":"10.1016\/j.ejmech.2026.119213_bib19","doi-asserted-by":"crossref","first-page":"12545","DOI":"10.1021\/acs.langmuir.0c01079","article-title":"Characterizing an siRNA-Containing lipid-nanoparticle prepared by a microfluidic reactor: small-angle X-ray scattering and cryotransmission electron microscopic studies","volume":"36","author":"Aburai","year":"2020","journal-title":"Langmuir"},{"key":"10.1016\/j.ejmech.2026.119213_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2022.02.017","article-title":"Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery","volume":"344","author":"Maeki","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.119213_bib21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3390\/pharmaceutics16121521","article-title":"Effect of lipid nanoparticle physico-chemical properties and composition on their interaction with the immune system","volume":"16","author":"Catenacci","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119213_bib22","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.119213_bib23","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","article-title":"A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human Primates","volume":"26","author":"Sabnis","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2026.119213_bib24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119213_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102721","article-title":"mRNA therapeutics: transforming medicine through innovation in design, delivery, and disease treatment","volume":"36","author":"Ige","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2026.119213_bib26","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/jpm14111092","article-title":"Advances in mRNA LNP-based cancer vaccines: mechanisms, formulation aspects, challenges, and future directions","volume":"14","author":"Ramadan","year":"2024","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.ejmech.2026.119213_bib27","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1002\/ctd2.33","article-title":"Restoring ornithine transcarbamylase (OTC) activity in an OTC-deficient mouse model using LUNAR-OTC mRNA","volume":"2","author":"Yu","year":"2022","journal-title":"Clinical and Translational Dis"},{"key":"10.1016\/j.ejmech.2026.119213_bib28","series-title":"Biontech, News","year":"2021"},{"key":"10.1016\/j.ejmech.2026.119213_bib29","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(17)31665-3","article-title":"Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial","volume":"390","author":"Alberer","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119213_bib30","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.vaccine.2020.12.070","article-title":"Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: a phase 1 trial","volume":"39","author":"Aldrich","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2026.119213_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2024.100512","article-title":"A phase 3, randomised, observer-blinded, placebo controlled-trial evaluating the safety and immunogenicity of investigational SARS-CoV-2 mRNA vaccine CVnCoV in adult healthcare workers in Mainz (Germany)","volume":"19","author":"Kowalzik","year":"2024","journal-title":"Vaccine X"},{"key":"10.1016\/j.ejmech.2026.119213_bib32","series-title":"Moderna, News","year":"2017"},{"key":"10.1016\/j.ejmech.2026.119213_bib33","doi-asserted-by":"crossref","first-page":"e668","DOI":"10.1093\/infdis\/jiae114","article-title":"Safety and immunogenicity of a messenger RNA-based cytomegalovirus vaccine in healthy adults: results from a phase 1 randomized clinical trial","volume":"230","author":"Fierro","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119213_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/infdis\/jiad593","article-title":"Human cytomegalovirus mRNA-1647 vaccine candidate elicits potent and broad neutralization and higher antibody-dependent cellular cytotoxicity responses than the gB\/MF59 vaccine","volume":"230","author":"Hu","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119213_bib35","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(22)00764-2","article-title":"The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials","volume":"23","author":"Essink","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119213_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf115","article-title":"First-in-human phase I\/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer","volume":"30","author":"Sullivan","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.ejmech.2026.119213_bib37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jamaoncol.2024.5927","article-title":"Intratumoral injection of mRNA-2752 and pembrolizumab for high-risk ductal carcinoma in situ: a phase 1 nonrandomized clinical trial","volume":"11","author":"Ramalingam","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ejmech.2026.119213_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108560","article-title":"Improved therapeutic efficacy in two mouse models of methylmalonic acidemia (MMA) using a second-generation mRNA therapy","volume":"143","author":"Coughlan","year":"2024","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejmech.2026.119213_bib39","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1038\/s41586-024-07646-z","article-title":"Publisher correction: interim analyses of a first-in-human phase 1\/2 mRNA trial for propionic acidaemia","volume":"630","author":"Koeberl","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119213_bib40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119213_bib41","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1172\/JCI134915","article-title":"mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer","volume":"130","author":"Cafri","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.119213_bib42","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","article-title":"Inhaled mRNA therapy for treatment of cystic fibrosis: interim results of a randomized, double-blind, placebo-controlled phase 1\/2 clinical study","volume":"22","author":"Rowe","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejmech.2026.119213_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1501365","article-title":"In vivo programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models","volume":"15","author":"Argueta","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.119213_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66087-y","article-title":"Organ-specific delivery of an mRNA-encoded bispecific T cell engager targeting glypican-3 in hepatocellular carcinoma","volume":"16","author":"Huang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119213_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/lifemedi\/lnac036","article-title":"NTLA-2001: opening a new era for gene therapy","volume":"1","author":"Cui","year":"2022","journal-title":"Life Med"},{"key":"10.1016\/j.ejmech.2026.119213_bib46","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1056\/NEJMoa2405734","article-title":"CRISPR-based therapy for hereditary angioedema","volume":"392","author":"Cohn","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119213_bib47","series-title":"Biontech, News","year":"2020"},{"key":"10.1016\/j.ejmech.2026.119213_bib48","doi-asserted-by":"crossref","first-page":"9556","DOI":"10.1200\/JCO.2025.43.16_suppl.9556","article-title":"Phase I dose escalation trial of STX-001, an LNP-encapsulated self-replicating mRNA expressing IL-12, in patients (pts) with advanced solid tumors","volume":"43","author":"Piha-Paul","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119213_bib49","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nature06917","article-title":"Imaging in the era of molecular oncology","volume":"452","author":"Weissleder","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119213_bib50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1101\/gad.1047403","article-title":"Molecular imaging in living subjects: seeing fundamental biological processes in a new light","volume":"17","author":"Massoud","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2026.119213_bib51","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.005355","article-title":"Molecular imaging in drug discovery and development","volume":"11","author":"Lindner","year":"2018","journal-title":"Circ., Cardiovasc. Imaging"},{"key":"10.1016\/j.ejmech.2026.119213_bib52","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrd2290","article-title":"Molecular imaging in drug development","volume":"7","author":"Willmann","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119213_bib53","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1152\/physrev.00049.2010","article-title":"A molecular imaging primer: modalities, imaging agents, and applications","volume":"92","author":"James","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119213_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.812270","article-title":"PET molecular imaging in drug development: the imaging and chemistry perspective","volume":"9","author":"Nerella","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.ejmech.2026.119213_bib55","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0969-8051(02)00345-1","article-title":"Accelerating drug discovery and development through in vivo imaging","volume":"29","author":"Eckelman","year":"2002","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2026.119213_bib56","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1161\/CIRCULATIONAHA.124.066522","article-title":"In vivo cardiovascular molecular imaging: contributions to precision medicine and drug development","volume":"150","author":"Lindner","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2026.119213_bib57","doi-asserted-by":"crossref","first-page":"27187","DOI":"10.1039\/D5RA03255E","article-title":"Advances in multimodal imaging techniques in nanomedicine: enhancing drug delivery precision","volume":"15","author":"Mishra","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119213_bib58","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s12951-022-01648-7","article-title":"In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications","volume":"20","author":"Refaat","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejmech.2026.119213_bib59","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrc3724","article-title":"Developments in preclinical cancer imaging: innovating the discovery of therapeutics","volume":"14","author":"Conway","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119213_bib60","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/acs.chemrev.6b00073","article-title":"Nanomaterials for in vivo imaging","volume":"117","author":"Smith","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119213_bib61","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119213_bib62","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/ar200106e","article-title":"Molecular imaging with theranostic nanoparticles","volume":"44","author":"Jokerst","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.119213_bib63","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/acs.analchem.3c04406","article-title":"Quantification of mRNA in lipid nanoparticles using mass spectrometry","volume":"96","author":"Lowenthal","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2026.119213_bib64","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/17576180.2024.2360361","article-title":"Biodistribution of lipid nanoparticle, eGFP mRNA and translated protein following subcutaneous administration in mouse","volume":"16","author":"Sandelius","year":"2024","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejmech.2026.119213_bib65","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein Corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119213_bib66","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s41120-025-00125-3","article-title":"Impact of cell line and reporter gene selection on in-vitro transfection evaluation of mRNA lipid nanoparticles","volume":"11","author":"Zhen","year":"2025","journal-title":"AAPS Open"},{"key":"10.1016\/j.ejmech.2026.119213_bib67","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1038\/s41467-024-50619-z","article-title":"AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119213_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.omtn.2017.11.005","article-title":"Rapid, single-cell analysis and discovery of vectored mRNA transfection in vivo with a loxP-Flanked tdTomato reporter Mouse","volume":"10","author":"Kauffman","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2026.119213_bib69","article-title":"Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver","volume":"7","author":"Kim","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119213_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202514370","article-title":"High-throughput in vivo screening using barcoded mRNA identifies lipid nanoparticles with extrahepatic tropism for in situ immunoengineering","volume":"38","author":"Hamilton","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejmech.2026.119213_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114598","article-title":"Screening lipid nanoparticles using DNA barcoding and qPCR","volume":"251","author":"Liu","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejmech.2026.119213_bib72","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41467-025-68103-7","article-title":"Multiplexed lipid nanoparticle barcoding reveals tissue-dynamic kinetic insights and enriched cellular tropism in hepatic zones","volume":"17","author":"Moore","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119213_bib73","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2967\/jnumed.116.181362","article-title":"Clinically approved nanoparticle imaging agents","volume":"57","author":"Thakor","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2026.119213_bib74","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1039\/C9NR00207C","article-title":"Liposome-based probes for molecular imaging: from basic research to the bedside","volume":"11","author":"Xia","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejmech.2026.119213_bib75","doi-asserted-by":"crossref","first-page":"11998","DOI":"10.1039\/D0SC04106H","article-title":"LDL-mimetic lipid nanoparticles prepared by surface KAT ligation for in vivo MRI of atherosclerosis","volume":"11","author":"Fracassi","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119213_bib76","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12645-020-00061-9","article-title":"Comparative study on contrast enhancement of Magnevist and Magnevist-loaded nanoparticles in pancreatic cancer PDX model monitored by MRI","volume":"11","author":"Affram","year":"2020","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.ejmech.2026.119213_bib77","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1039\/B910561A","article-title":"A novel bimodal lipidic contrast agent for cellular labelling and tumour MRI","volume":"8","author":"Kamaly","year":"2010","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2026.119213_bib78","doi-asserted-by":"crossref","DOI":"10.1117\/1.3213606","article-title":"Cyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging","volume":"14","author":"Texier","year":"2009","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.ejmech.2026.119213_bib79","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejpb.2010.02.007","article-title":"Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging","volume":"75","author":"Goutayer","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejmech.2026.119213_bib80","doi-asserted-by":"crossref","first-page":"255","DOI":"10.52601\/bpr.2023.230022","article-title":"Surface engineering of lipid nanoparticles: targeted nucleic acid delivery and beyond","volume":"9","author":"Lin","year":"2023","journal-title":"Biophys Rep"},{"key":"10.1016\/j.ejmech.2026.119213_bib81","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2024.05.036","article-title":"EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta","volume":"371","author":"Geisler","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.119213_bib82","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41565-017-0043-5","article-title":"A modular platform for targeted RNAi therapeutics","volume":"13","author":"Kedmi","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejmech.2026.119213_bib83","series-title":"Cell Tracking","first-page":"33","article-title":"Lipophilic near-infrared dyes for in vivo fluorescent cell tracking","author":"Basel","year":"2020"},{"key":"10.1016\/j.ejmech.2026.119213_bib84","doi-asserted-by":"crossref","first-page":"16151","DOI":"10.1021\/acsnano.4c01171","article-title":"High-throughput In Vivo screening identifies differential influences on mRNA lipid nanoparticle immune cell delivery by administration route","volume":"18","author":"Hamilton","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2026.119213_bib85","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1039\/D4TB02653E","article-title":"Capturing the dynamic integrity of carbocyanine fluorophore-based lipid nanoparticles using the FRET technique","volume":"13","author":"Long","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejmech.2026.119213_bib86","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4994","article-title":"Fluorescent labeling and imaging of IL-22 mRNA-Loaded lipid nanoparticles","volume":"14","author":"Mow","year":"2024","journal-title":"Bio Protoc"},{"key":"10.1016\/j.ejmech.2026.119213_bib87","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1038\/s41467-025-60959-z","article-title":"Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol","volume":"16","author":"Johansson","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119213_bib88","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2020.06.030","article-title":"Theranostic dendrimer-based lipid nanoparticles containing PEGylated BODIPY dyes for tumor imaging and systemic mRNA delivery in vivo","volume":"325","author":"Xiong","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.119213_bib89","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.nano.2015.06.013","article-title":"Environment-responsive aza-BODIPY dyes quenching in water as potential probes to visualize the in vivo fate of lipid-based nanocarriers","volume":"11","author":"Hu","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejmech.2026.119213_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102325","article-title":"The dynamic process of mRNA delivery by lipid nanoparticles in vivo","volume":"57","author":"Ma","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.ejmech.2026.119213_bib91","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2311276120","article-title":"Biomimetic noncationic lipid nanoparticles for mRNA delivery","volume":"120","author":"Wang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.119213_bib92","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500605","article-title":"Nanobody-decorated lipid nanoparticles for enhanced mRNA delivery to tumors in vivo","volume":"14","author":"Escud\u00e9 Martinez De Castilla","year":"2025","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ejmech.2026.119213_bib93","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41541-024-00900-5","article-title":"Distinct dynamics of mRNA LNPs in mice and nonhuman Primates revealed by in vivo imaging","volume":"9","author":"Lemdani","year":"2024","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.ejmech.2026.119213_bib94","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41551-019-0378-3","article-title":"Visualization of early events in mRNA vaccine delivery in non-human primates via PET\u2013CT and near-infrared imaging","volume":"3","author":"Lindsay","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ejmech.2026.119213_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/srep15641","article-title":"Tumor-induced lymph node alterations detected by MRI lymphography using gadolinium nanoparticles","volume":"5","author":"Partridge","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119213_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013082","article-title":"Novel Gd nanoparticles enhance vascular contrast for high-resolution magnetic resonance imaging","volume":"5","author":"Bui","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119213_bib97","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1248\/bpb.b13-00484","article-title":"Folate-targeted gadolinium-lipid-based nanoparticles as a bimodal contrast agent for tumor fluorescent and magnetic resonance imaging","volume":"37","author":"Nakamura","year":"2014","journal-title":"Biol. Pharmaceut. Bull."},{"key":"10.1016\/j.ejmech.2026.119213_bib98","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1039\/C6NR08496F","article-title":"Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents","volume":"9","author":"Luo","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejmech.2026.119213_bib99","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13046-024-03167-9","article-title":"Co-delivery of camptothecin and MiR-145 by lipid nanoparticles for MRI-Visible targeted therapy of hepatocellular carcinoma","volume":"43","author":"Rong","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119213_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202503055","article-title":"Magnetic resonance imaging-based quantification of endosomal escape using iron oxide nanoparticle-loaded lipid nanoparticles","volume":"14","author":"Lee","year":"2025","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ejmech.2026.119213_bib101","doi-asserted-by":"crossref","first-page":"15053","DOI":"10.1039\/C9RA02529D","article-title":"Magnetoliposomes with size controllable insertion of magnetic nanoparticles for efficient targeting of cancer cells","volume":"9","author":"Choi","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119213_bib102","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ymthe.2025.01.008","article-title":"Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates","volume":"33","author":"Buckley","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2026.119213_bib103","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1038\/s41467-025-58523-w","article-title":"Liposomal lipid nanoparticles for extrahepatic delivery of mRNA","volume":"16","author":"Cheng","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119213_bib104","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adv2293","article-title":"Metabolism-programming mRNA-lipid nanoparticles remodel the immune microenvironment to improve immunotherapy against MAFLD","volume":"17","author":"Yu","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119213_bib105","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1038\/s41467-025-57446-w","article-title":"Monitoring mRNA vaccine antigen expression in vivo using PET\/CT","volume":"16","author":"Blizard","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119213_bib106","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s44303-026-00142-1","article-title":"A single-step radiolabeling strategy for PET, SPECT, and therapeutic radionuclides using nanoparticles as a universal chelator","volume":"4","author":"Herraiz","year":"2026","journal-title":"Npj Imaging"},{"key":"10.1016\/j.ejmech.2026.119213_bib107","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.119213_bib115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.119213_bib108","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1038\/emboj.2011.286","article-title":"Endosome maturation","volume":"30","author":"Huotari","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2026.119213_bib109","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-015-0041-1","article-title":"The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration","volume":"4","author":"Hu","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejmech.2026.119213_bib110","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.3390\/molecules29245997","article-title":"Endosomal escape and nuclear localization: critical barriers for therapeutic nucleic acids","volume":"29","author":"Allen","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119213_bib111","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: a bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2026.119213_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10213","article-title":"Cytosolic delivery of nucleic acids: the case of ionizable lipid nanoparticles","volume":"6","author":"Schlich","year":"2021","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119213_bib114","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nbt.3298","article-title":"Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown","volume":"33","author":"Wittrup","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.119213_bib113","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1038\/s41467-019-12275-6","article-title":"Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells","volume":"10","author":"Maugeri","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119213_bib116","doi-asserted-by":"crossref","DOI":"10.1038\/srep32301","article-title":"Enhancing endosomal escape for intracellular delivery of macromolecular biologic therapeutics","volume":"6","author":"L\u00f6nn","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119213_bib117","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2500from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2026.119213_bib118","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11095-025-03890-8","article-title":"Mechanism of pH-sensitive amphiphilic endosomal escape of ionizable lipid nanoparticles for cytosolic nucleic acid delivery","volume":"42","author":"Lu","year":"2025","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2026.119213_bib119","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1021\/jacs.2c10670","article-title":"Iterative design of ionizable lipids for intramuscular mRNA delivery","volume":"145","author":"Tilstra","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119213_bib120","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41551-024-01267-7","article-title":"Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolution","volume":"8","author":"Han","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ejmech.2026.119213_bib121","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501037","article-title":"Rational design of unsaturated, thioether ionizable lipids for enhanced in vivo mRNA delivery","volume":"14","author":"Samaridou","year":"2025","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ejmech.2026.119213_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124868","article-title":"Multiple tail ionizable lipids improve in vivo mRNA delivery efficiency with biosafety","volume":"667","author":"Liu","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2026.119213_bib123","article-title":"Rational design and modular synthesis of biodegradable ionizable lipids via the Passerini reaction for mRNA delivery","volume":"122","author":"Xu","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2026.119213_bib141","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2026.119213_bib153","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2026.119213_bib124","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwae135","article-title":"Minimizing the ratio of ionizable lipid in lipid nanoparticles for in vivo base editing","volume":"11","author":"Chen","year":"2024","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.ejmech.2026.119213_bib125","doi-asserted-by":"crossref","first-page":"eadx5970","DOI":"10.1126\/sciadv.adx5970","article-title":"Ionizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy","volume":"11","author":"Zhang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119213_bib126","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/D0NA00454E","article-title":"Nanoscopy for endosomal escape quantification","volume":"3","author":"Andrian","year":"2021","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.ejmech.2026.119213_bib127","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.mex.2015.06.001","article-title":"Cellular imaging of endosome entrapped small gold nanoparticles","volume":"2","author":"Kim","year":"2015","journal-title":"MethodsX"},{"key":"10.1016\/j.ejmech.2026.119213_bib128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s42003-021-01728-8","article-title":"A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery","volume":"4","author":"Munson","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2026.119213_bib129","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1039\/D0BM01947J","article-title":"Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery","volume":"9","author":"Herrera","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejmech.2026.119213_bib130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fphar.2019.00010","article-title":"A smart pH-Sensitive delivery system for enhanced anticancer efficacy via Paclitaxel endosomal escape","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119213_bib131","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1021\/acs.analchem.9b00877","article-title":"Self-assembly of luminescent gold nanoparticles with sensitive pH-Stimulated structure transformation and emission response toward lysosome escape and intracellular imaging","volume":"91","author":"Zhu","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2026.119213_bib132","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s10544-015-9947-8","article-title":"Quantification of nanoparticle endocytosis based on double fluorescent pH-sensitive nanoparticles","volume":"17","author":"Kurtz-Chalot","year":"2015","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.ejmech.2026.119213_bib133","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.ymthe.2019.07.018","article-title":"Endocytic profiling of cancer cell models reveals critical factors influencing LNP-mediated mRNA delivery and protein expression","volume":"27","author":"Sayers","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2026.119213_bib134","doi-asserted-by":"crossref","first-page":"30907","DOI":"10.1021\/jacs.5c07897","article-title":"mRNA-Based FRET-FLIM imaging platform for quantifying lipid nanoparticle endosomal escape and membrane damage","volume":"147","author":"Fang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119213_bib135","article-title":"Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale","volume":"221","author":"Paramasivam","year":"2022","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.ejmech.2026.119213_bib151","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11095-022-03166-5","article-title":"Biodistribution and non-linear gene expression of mRNA LNPs affected by delivery route and particle size","volume":"39","author":"Di","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2026.119213_bib150","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41565-025-01958-5","article-title":"Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications","volume":"20","author":"Vadovics","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejmech.2026.119213_bib136","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3390\/molecules30081729","article-title":"Liposomes for magnetic resonance image-guided drug delivery; lipid chain length affects drug release and MRI relaxivity","volume":"30","author":"Cressey","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119213_bib137","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2024.11.010","article-title":"Exploring the impact of commonly used ionizable and pegylated lipids on LNP-mRNAs: a combined in vitro and preclinical perspective","volume":"377","author":"Binici","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.119213_bib138","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo1827","article-title":"Structural and biochemical characteristics of mRNA nanoparticles determine anti\u2013SARS-CoV-2 humoral and cellular immune responses","volume":"8","author":"Shi","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119213_bib139","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1021\/acs.molpharmaceut.2c01024","article-title":"Delivery and expression of mRNA in the secondary lymphoid organs drive immune responses to lipid Nanoparticle-mRNA vaccines after intramuscular injection","volume":"20","author":"Takanashi","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.119213_bib140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4049\/jimmunol.2300500","article-title":"Modulating antigen availability in lymphoid organs to shape the humoral immune response to vaccines","volume":"212","author":"Aung","year":"2024","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2026.119213_bib142","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2505718122","article-title":"Circular RNA lipid nanoparticle vaccine against SARS-CoV-2","volume":"122","author":"Swingle","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.119213_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012502","article-title":"Development of a lipid-encapsulated TGF\u03b2RI-siRNA drug for liver fibrosis induced by Schistosoma mansoni","volume":"18","author":"Chen","year":"2024","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2026.119213_bib144","article-title":"A combinatorial library of lipid nanoparticles for cell type-specific mRNA delivery","volume":"10","author":"Naidu","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ejmech.2026.119213_bib145","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s42003-021-02441-2","article-title":"Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration","volume":"4","author":"Carrasco","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2026.119213_bib146","doi-asserted-by":"crossref","first-page":"9627","DOI":"10.1021\/acsnano.0c10180","article-title":"Design of SARS-CoV-2 hFc-Conjugated receptor-binding domain mRNA vaccine delivered via lipid nanoparticles","volume":"15","author":"Elia","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2026.119213_bib147","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1039\/D1BM01454D","article-title":"Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA)","volume":"10","author":"\u00c1lvarez-Benedicto","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejmech.2026.119213_bib148","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.xphs.2022.12.026","article-title":"Effect of cholesterol content of lipid composition in LNP-mRNAs on the protein expression in the injected site and liver after local administration in mice","volume":"112","author":"Kawaguchi","year":"2023","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2026.119213_bib152","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jconrel.2024.07.059","article-title":"Effects of phospholipid type and particle size on lipid nanoparticle distribution in vivo and in pancreatic islets","volume":"373","author":"Oguma","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.119213_bib149","article-title":"Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity","volume":"6","author":"Tursi","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119213_bib178","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/vaccines9010065","article-title":"Nanomaterial delivery systems for mRNA vaccines","volume":"9","author":"Buschmann","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.ejmech.2026.119213_bib154","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejmech.2026.119213_bib176","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202211420","article-title":"Optimizing lipid nanoparticles for delivery in Primates","volume":"35","author":"Lam","year":"2023","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119213_bib177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-5926-1-1","article-title":"Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review","volume":"1","author":"Braet","year":"2002","journal-title":"Comp. Hepatol."},{"key":"10.1016\/j.ejmech.2026.119213_bib155","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.omto.2021.03.006","article-title":"A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy","volume":"21","author":"Concilio","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ejmech.2026.119213_bib156","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1073\/pnas.96.5.2333","article-title":"Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography","volume":"96","author":"Gambhir","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.119213_bib157","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc882","article-title":"Molecular imaging of cancer with positron emission tomography","volume":"2","author":"Gambhir","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119213_bib158","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2026.119213_bib159","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2021.12.027","article-title":"Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)","volume":"344","author":"Parhiz","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.119213_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The LNP-mRNA platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.ejmech.2026.119213_bib161","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s12276-023-00999-x","article-title":"Knife's edge: balancing immunogenicity and reactogenicity in mRNA vaccines","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.119213_bib162","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/jbm.a.37356","article-title":"Rational design of anti-inflammatory lipid nanoparticles for mRNA delivery","volume":"110","author":"Zhang","year":"2022","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ejmech.2026.119213_bib163","doi-asserted-by":"crossref","first-page":"27977","DOI":"10.1021\/acsnano.5c10648","article-title":"Modulating immunogenicity and reactogenicity in mRNA-Lipid nanoparticle vaccines through lipid component optimization","volume":"19","author":"Kawaguchi","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2026.119213_bib169","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nbt1402","article-title":"A combinatorial library of lipid-like materials for delivery of RNAi therapeutics","volume":"26","author":"Akinc","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.119213_bib170","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/s41467-024-45537-z","article-title":"In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors","volume":"15","author":"Han","year":"2024","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119213_bib171","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.bbalip.2016.12.006","article-title":"Archaeal phospholipids: structural properties and biosynthesis","volume":"1862","author":"Caforio","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ejmech.2026.119213_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114213","article-title":"Archaeal ether lipids improve internalization and transfection with mRNA lipid nanoparticles","volume":"197","author":"Sedlmayr","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejmech.2026.119213_bib173","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.7150\/thno.31914","article-title":"Gene delivery based on macrocyclic amphiphiles","volume":"9","author":"Geng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2026.119213_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122776","article-title":"\u03b2-Cyclodextrin-based geometrically frustrated amphiphiles as one-component, cell-specific and organ-specific nucleic acid delivery systems","volume":"347","author":"Rivero-Barbarroja","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejmech.2026.119213_bib175","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s11095-015-1796-x","article-title":"Aerosolized non-viral nucleic acid delivery in the vaginal tract of pigs","volume":"33","author":"Remaut","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2026.119213_bib166","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ymthe.2025.01.020","article-title":"Low-inflammatory lipid nanoparticles facilitate safe mRNA vaccination against influenza virus infection","volume":"33","author":"Xu","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2026.119213_bib167","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ymthe.2024.12.032","article-title":"Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 influenza virus with reduced adverse reactions","volume":"33","author":"Kawai","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2026.119213_bib168","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1038\/s41467-025-61688-z","article-title":"Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury","volume":"16","author":"Zhao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119213_bib164","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1016\/j.biomaterials.2010.05.027","article-title":"The systemic toxicity of positively charged lipid nanoparticles and the role of toll-like receptor 4 in immune activation","author":"Kedmi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2026.119213_bib165","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/0300985817738095","article-title":"Safety evaluation of lipid nanoparticle-formulated modified mRNA in the sprague-dawley rat and cynomolgus monkey","volume":"55","author":"Sedic","year":"2018","journal-title":"Vet. Pathol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:13:50Z","timestamp":1788048830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426006586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":178,"alternative-id":["S0223523426006586"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119213","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo imaging of lipid nanoparticle messenger RNA therapeutics: Current advances and emerging opportunities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119213"}}